These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 24998634)

  • 21. [Quantitative analysis of the genes determining spinal muscular atrophy].
    Nagymihály M; Herczegfalvi A; Tímár L; Karcagi V
    Ideggyogy Sz; 2009 Nov; 62(11-12):390-7. PubMed ID: 20025129
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Frequency of C9orf72 repeat expansions in amyotrophic lateral sclerosis: a Belgian cohort study.
    Debray S; Race V; Crabbé V; Herdewyn S; Matthijs G; Goris A; Dubois B; Thijs V; Robberecht W; Van Damme P
    Neurobiol Aging; 2013 Dec; 34(12):2890.e7-2890.e12. PubMed ID: 23870417
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intermediate repeat expansion length in C9orf72 may be pathological in amyotrophic lateral sclerosis.
    Byrne S; Heverin M; Elamin M; Walsh C; Hardiman O
    Amyotroph Lateral Scler Frontotemporal Degener; 2014 Mar; 15(1-2):148-50. PubMed ID: 24053774
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular analysis of SMN1, SMN2, NAIP, GTF2H2, and H4F5 genes in 157 Chinese patients with spinal muscular atrophy.
    He J; Zhang QJ; Lin QF; Chen YF; Lin XZ; Lin MT; Murong SX; Wang N; Chen WJ
    Gene; 2013 Apr; 518(2):325-9. PubMed ID: 23352792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions.
    Tan RH; Kril JJ; McGinley C; Hassani M; Masuda-Suzukake M; Hasegawa M; Mito R; Kiernan MC; Halliday GM
    Ann Neurol; 2016 Feb; 79(2):295-305. PubMed ID: 26599997
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Molecular basis of spinal muscular atrophy: th SMN gene].
    Tizzano E; Baiget M
    Neurologia; 2000 Nov; 15(9):393-400. PubMed ID: 11195146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of function of C9orf72 causes motor deficits in a zebrafish model of amyotrophic lateral sclerosis.
    Ciura S; Lattante S; Le Ber I; Latouche M; Tostivint H; Brice A; Kabashi E
    Ann Neurol; 2013 Aug; 74(2):180-7. PubMed ID: 23720273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and characterization of an SMN2-based intermediate mouse model of Spinal Muscular Atrophy.
    Cobb MS; Rose FF; Rindt H; Glascock JJ; Shababi M; Miller MR; Osman EY; Yen PF; Garcia ML; Martin BR; Wetz MJ; Mazzasette C; Feng Z; Ko CP; Lorson CL
    Hum Mol Genet; 2013 May; 22(9):1843-55. PubMed ID: 23390132
    [TBL] [Abstract][Full Text] [Related]  

  • 29. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS.
    Corcia P; Camu W; Halimi JM; Vourc'h P; Antar C; Vedrine S; Giraudeau B; de Toffol B; Andres CR;
    Neurology; 2006 Oct; 67(7):1147-50. PubMed ID: 16931506
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The study of the correlation between the clinical phenotype of spinal muscular atrophy and SMN2 gene copy number].
    Lu LP; Ma HW; Jiang J; Wang T; Hu B
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Apr; 24(2):144-7. PubMed ID: 17407069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiac defects contribute to the pathology of spinal muscular atrophy models.
    Shababi M; Habibi J; Yang HT; Vale SM; Sewell WA; Lorson CL
    Hum Mol Genet; 2010 Oct; 19(20):4059-71. PubMed ID: 20696672
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of the repeat expansion size in C9orf72 in amyotrophic lateral sclerosis and frontotemporal dementia.
    Dols-Icardo O; García-Redondo A; Rojas-García R; Sánchez-Valle R; Noguera A; Gómez-Tortosa E; Pastor P; Hernández I; Esteban-Pérez J; Suárez-Calvet M; Antón-Aguirre S; Amer G; Ortega-Cubero S; Blesa R; Fortea J; Alcolea D; Capdevila A; Antonell A; Lladó A; Muñoz-Blanco JL; Mora JS; Galán-Dávila L; Rodríguez De Rivera FJ; Lleó A; Clarimón J
    Hum Mol Genet; 2014 Feb; 23(3):749-54. PubMed ID: 24057670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phenotype modifiers of spinal muscular atrophy: the number of SMN2 gene copies, deletion in the NAIP gene and probably gender influence the course of the disease.
    Jedrzejowska M; Milewski M; Zimowski J; Borkowska J; Kostera-Pruszczyk A; Sielska D; Jurek M; Hausmanowa-Petrusewicz I
    Acta Biochim Pol; 2009; 56(1):103-8. PubMed ID: 19287802
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel genome-editing-based approaches to treat motor neuron diseases: Promises and challenges.
    Miccio A; Antoniou P; Ciura S; Kabashi E
    Mol Ther; 2022 Jan; 30(1):47-53. PubMed ID: 33823304
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination of SMN2 copy number and NAIP deletion predicts disease severity in spinal muscular atrophy.
    Watihayati MS; Fatemeh H; Marini M; Atif AB; Zahiruddin WM; Sasongko TH; Tang TH; Zabidi-Hussin ZA; Nishio H; Zilfalil BA
    Brain Dev; 2009 Jan; 31(1):42-5. PubMed ID: 18842367
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The relationship of spinal muscular atrophy to motor neuron disease: investigation of SMN and NAIP gene deletions in sporadic and familial ALS.
    Orrell RW; Habgood JJ; de Belleroche JS; Lane RJ
    J Neurol Sci; 1997 Jan; 145(1):55-61. PubMed ID: 9073029
    [TBL] [Abstract][Full Text] [Related]  

  • 37. C9ORF72 hexanucleotide repeat expansion is a rare cause of schizophrenia.
    Galimberti D; Reif A; Dell'osso B; Kittel-Schneider S; Leonhard C; Herr A; Palazzo C; Villa C; Fenoglio C; Serpente M; Cioffi SM; Prunas C; Paoli RA; Altamura AC; Scarpini E
    Neurobiol Aging; 2014 May; 35(5):1214.e7-1214.e10. PubMed ID: 24387986
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adult-onset spinal muscular atrophy: An update.
    Juntas Morales R; Pageot N; Taieb G; Camu W
    Rev Neurol (Paris); 2017 May; 173(5):308-319. PubMed ID: 28456383
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinobulbar muscular atrophy can mimic ALS: the importance of genetic testing in male patients with atypical ALS.
    Parboosingh JS; Figlewicz DA; Krizus A; Meininger V; Azad NA; Newman DS; Rouleau GA
    Neurology; 1997 Aug; 49(2):568-72. PubMed ID: 9270598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A PCR-based protocol to accurately size C9orf72 intermediate-length alleles.
    Biasiotto G; Archetti S; Di Lorenzo D; Merola F; Paiardi G; Borroni B; Alberici A; Padovani A; Filosto M; Bonvicini C; Caimi L; Zanella I
    Mol Cell Probes; 2017 Apr; 32():60-64. PubMed ID: 27765650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.